$11.29
-2.47 (-17.92%)
At Close: Jun 03, 2026
Contrasting Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Biostage (OTCMKTS:BSTG)
03:07am, Sunday, 26'th Apr 2026
Defiance Daily Target 2X Long LMND ETF (NASDAQ: LMNX - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will
Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Critical Comparison
03:20am, Tuesday, 21'st Apr 2026
Institutional and Insider Ownership 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. Comparatively, 87.8% of Defiance Daily Target 2X Long LMND ETF shares are he
Financial Contrast: Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) vs. Minerva Surgical (NASDAQ:UTRS)
01:09am, Tuesday, 14'th Apr 2026
Valuation and Earnings This table compares Defiance Daily Target 2X Long LMND ETF and Minerva Surgical"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Ear
5 Best-Performing Leveraged ETFs of Last Week
12:01pm, Tuesday, 24'th Mar 2026
Leveraged ETFs surged amid market turmoil as stocks slid and commodities swung wildly. Inverse plays dominated -- here are last week's top winners.
Best-Performing Leveraged ETFs of Last Week
01:00pm, Monday, 26'th Jan 2026
USAR-linked leveraged ETFs soared last week as rare-earth stocks jumped, while natural gas and gold plays surged amid tariffs and winter shocks.
Defiance Launches LMNX: The First 2X Long ETF for Lemonade, Inc.
08:30am, Thursday, 16'th Oct 2025
MIAMI, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs is proud to announce the launch of the Defiance Daily Target 2X Long LMND ETF (Ticker: LMNX) , expanding its suite of single-stock leveraged ET
Luminex Corporation Declares Second Quarter Cash Dividend
04:30pm, Thursday, 20'th May 2021
AUSTIN, Texas, May 20, 2021 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the second quarter of 2021 of $0
DiaSorin: Surfing The COVID-19 Wave, Culminating In A $1.8 Billion Acquisition Of Luminex
04:00am, Thursday, 06'th May 2021
DiaSorin is a world leader in the sale of reagents to laboratories. It converts about 25-30% of its revenue into free cash flow.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Luminex Corp. - LMNX
09:37pm, Friday, 16'th Apr 2021
NEW YORK, April 16, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Cla
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Luminex Corp
Strength Seen in Luminex (LMNX): Can Its 12.4% Jump Turn into More Strength?
06:04am, Tuesday, 13'th Apr 2021
Luminex (LMNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
INVESTIGATION ALERT: Halper Sadeh LLP Investigates LMNX, NUAN, CADE, GNMK; Shareholders are Encouraged to Contact the Firm
04:08am, Tuesday, 13'th Apr 2021
NEW YORK, April 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Luminex Corporation (NASDAQ: LMNX) concerning po
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Luminex Corporation
06:00pm, Monday, 12'th Apr 2021
NEW YORK, April 12, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Luminex Corporation (NASDAQ: LMNX) and its board of directors concerning the proposed
Italian Diagnostic Developer Calls Luminex a 'Perfect Fit'
04:43pm, Monday, 12'th Apr 2021
Investors reacted favorably over the announcement that Saluggia, Italy-based DiaSorin SpA (MIL:DIA) is paying $1.8 billion to purchase Austin, Texas-based Luminex Corp. (NASDAQ:LMNX), a developer of p
SHAREHOLDER ALERT: WeissLaw LLP Investigates Luminex Corporation
02:48pm, Monday, 12'th Apr 2021
NEW YORK, April 12, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Luminex Corporation ("Luminex" or
Sign In
Buy LMNX